Radical retropubic prostatectomy in Hispanic patients.

Area of Science:

• Urology
• Oncology
• Health Disparities

Background:

• Hispanics are the largest US minority group, yet studies on prostatectomy outcomes often exclude them.
• Limited research exists on radical prostatectomy (RRP) outcomes specifically for Hispanic men.
• This study addresses the gap by analyzing RRP in Hispanic patients.

Purpose of the Study:

• To analyze the presentation and outcomes of Hispanic males undergoing radical prostatectomy (RRP).
• To compare the outcomes of Hispanic patients with white non-Hispanic patients after RRP.
• To assess if ethnicity impacts biochemical disease recurrence after prostatectomy.

Main Methods:

• A comparative analysis was performed between 207 Hispanic and 518 white non-Hispanic patients who underwent RRP.
• Patients were categorized by ethnicity, with African-Americans and other minorities excluded due to small sample sizes.
• Data analyzed included presentation, pathological findings, neoadjuvant therapy, and biochemical recurrence rates.

Main Results:

• The mean follow-up was 46.9 months.
• Hispanic patients showed similar rates of lymph node metastasis, seminal vesicle invasion, and extraprostatic extension compared to white non-Hispanic patients.
• The biochemical disease recurrence rate was 12% in Hispanic patients, with no significant difference compared to the white non-Hispanic group.

Conclusions:

• Hispanic patients treated with radical prostatectomy for prostate cancer exhibit similar presentation, pathological findings, and outcomes as white non-Hispanic patients.
• These findings suggest ethnicity is not a significant factor in RRP outcomes for prostate cancer.
• Further research may explore other factors influencing prostate cancer outcomes in diverse populations.